Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 14, 2016

Brainlab enters into deal with Dalhousie University for next generation radiosurgery software

German software-driven medical technology developer Brainlab has entered into an intellectual property license agreement with Atlantic Canada's leading research-intensive Dalhousie University for an integration with the next generation radiosurgery software.

Brainlab

German software-driven medical technology developer Brainlab has entered into an intellectual property license agreement with Atlantic Canada’s leading research-intensive Dalhousie University for an integration with the next generation radiosurgery software.

The new radiosurgery software can be customised in accordance with the patient’s needs, its optimised arc-trajectories are aimed at decreasing the radiation dose emitted to organs infected without compromising on target coverage.

The new algorithms of the software create a suitability ranking for every gantry and couch-position based on geometric overlap of multiple risk organs and the target volume, and takes into consideration the relative depth of structures and dose tolerances.

The algorithm can supplement regions of approach which allow the most rapid dose fall-off toward specific organs at risk. The optimisation can be applied to fixed couch arcs as well as simultaneous gantry-couch movements.

"For patients, this means that we can further limit dose to healthy organs surrounding the tumour, without extending treatment times."

Dalhousie University medical physics chief James Robar said: "We have developed an effective method for trajectory based treatment planning and delivery, often referred to as the four-Pi approach.

"In addition to minimising peripheral dose, the new algorithm alleviates the need for beam modulation, increasing the efficiency of planning and treatment delivery.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 
Ensuring quality and supply chain visibility for medical device components

"For patients, this means that we can further limit dose to healthy organs surrounding the tumour, without extending treatment times."

Headquartered in Munich, Brainlab is the developer, manufacturer and marketer of software-driven medical technology which allows an access to advanced, less invasive patient treatments.


Image: A drawing of a heart. Photo: courtesy of Business Wire.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU